Aurora Labs' Intents Connect now supports Sui as a destination for one-signature cross-chain transactions, allowing users to fund and complete actions like lending, trading, or staking on Sui directly from other blockchains without separate bridging or wallet changes. This integration removes the need for users to manage SUI gas fees or switch wallets, streamlining the process through a single signature. The system uses NEAR Intents for liquidity and settlement, and supports developers by providing a unified connection to multiple blockchains. This advancement is significant as it overcomes Sui's unique technical challenges and expands access to its growing DeFi ecosystem, which includes lending and stablecoin products.
Aurora Labs' Intents Connect integration with Sui is highlighted alongside a strong market breadth where 46 of 50 major cryptocurrencies on Pluang rose as of Sep 18, 2026 02:32 WIB. For readers following cryptocurrency markets, here is Pluang's snapshot: AAVE rose 10.78% to Rp2.260.828 with 86% buy orders and a typical hold time of 105 days; CAKE increased 10.13% to Rp43.150 with 57% sell orders; DOT gained 9.82% to Rp18.933 with 75% buy orders and a typical hold time of 120 days.
KB Home is set to report its Q3 2026 earnings on September 22, with analysts projecting a 45.3% drop in earnings per share to around $0.89 and a 20.2% decline in revenue to about $1.30 billion compared to last year. The consensus EPS estimate has rec...
An investment of $10,000 in Nebius when it resumed trading in 2024 has grown significantly to approximately $105,000 by 2026. This remarkable increase highlights Nebius's strong market performance over the two-year period. Investors who bought in at ...
W.P. Carey expects to invest over $1.9 billion in 2026, reflecting robust growth in its net lease property portfolio. Despite a slight reduction in its price target by Scotiabank to $76, the stock still shows potential upside from current levels. The...
Micron Technology is investing $10 billion over the next decade to establish Micron Research Labs, a new division focused on future memory architectures and advanced semiconductor manufacturing. The company shows strong financial health with a low de...
Impact Biomedical Inc. will conduct a 1-for-12.62 reverse stock split on September 23, 2026, consolidating shares without changing shareholder value. This move facilitates its planned merger with Zoar Ltd., with a Form F-4 registration filed with the...
